Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest
Kyoko Oura, Tomoko Tadokoro, Shintaro Fujihara, et al.
Oncology Reports (2017) Vol. 38, Iss. 5, pp. 2825-2835
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence
Nabil V. Sayour, Ágnes Paál, Pietro Ameri, et al.
European Heart Journal (2024) Vol. 45, Iss. 14, pp. 1224-1240
Open Access | Times Cited: 19
Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA
Tomoko Tadokoro, Asahiro Morishita, Tsutomu Masaki
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8139-8139
Open Access | Times Cited: 60
The renin-angiotensin-aldosterone system (RAAS) signaling pathways and cancer: foes versus allies
Bahareh Hassani, Zeinab Attar, Negar Firouzabadi
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 24
The Effect of Local Renin Angiotensin System in the Common Types of Cancer
Moudhi Almutlaq, Abir Alamro, Hassan S. Alamri, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 44
Repurposing drugs targeting metabolic diseases for cancer therapeutics
Jisha Pillai U, Anindita Ray, Meenu Maan, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 9, pp. 103684-103684
Closed Access | Times Cited: 18
The mechanisms of renin–angiotensin system in hepatocellular carcinoma: From the perspective of liver fibrosis, HCC cell proliferation, metastasis and angiogenesis, and corresponding protection measures
Haifeng Zhang, Xiang Gao, Xuan Wang, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111868-111868
Open Access | Times Cited: 36
Repurposing of Chronically Used Drugs in Cancer Therapy: A Chance to Grasp
Mohamad Ali Hijazi, André Gessner, Nahed El‐Najjar
Cancers (2023) Vol. 15, Iss. 12, pp. 3199-3199
Open Access | Times Cited: 16
Immunomodulatory Effects of Drugs for Effective Cancer Immunotherapy
Maiko Matsushita, Mai Kawaguchi
Journal of Oncology (2018) Vol. 2018, pp. 1-7
Open Access | Times Cited: 43
Telmisartan Inhibits Cell Proliferation and Tumor Growth of Esophageal Squamous Cell Carcinoma by Inducing S-Phase Arrest In Vitro and In Vivo
Takanori Matsui, Taiga Chiyo, Hideki Kobara, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 13, pp. 3197-3197
Open Access | Times Cited: 37
Angiotensin II and Angiotensin Receptors 1 and 2—Multifunctional System in Cells Biology, What Do We Know?
Maksymilian Ziaja, Kinga Anna Urbanek, Karolina Kowalska, et al.
Cells (2021) Vol. 10, Iss. 2, pp. 381-381
Open Access | Times Cited: 32
Peroxisome proliferator-activated receptor gamma as a therapeutic target for hepatocellular carcinoma: Experimental and clinical scenarios
Swati Katoch, Vinesh Sharma, Vikram Patial
World Journal of Gastroenterology (2022) Vol. 28, Iss. 28, pp. 3535-3554
Open Access | Times Cited: 22
Nanofabrications of Erythrocyte Membrane-Coated Telmisartan Delivery System Effective for Radiosensitivity of Tumor Cells in Mice Model
Shaoqing Chen, Cheng Wang, Yanyan Meng, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 1487-1508
Open Access | Times Cited: 4
Drug repurposing: An emerging strategy in alleviating skin cancer
Popat Kumbhar, Kapil Kole, Tejashree Yadav, et al.
European Journal of Pharmacology (2022) Vol. 926, pp. 175031-175031
Closed Access | Times Cited: 18
Inhibition of angiotensin pathway via valsartan reduces tumor growth in models of colorectal cancer
Fereshteh Asgharzadeh, Asma Mostafapour, Safieh Ebrahimi, et al.
Toxicology and Applied Pharmacology (2022) Vol. 440, pp. 115951-115951
Closed Access | Times Cited: 17
Investigation of the impact of rosuvastatin and telmisartan in doxorubicin-induced acute cardiotoxicity
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Afrah F. Alkhuriji, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113673-113673
Open Access | Times Cited: 17
Prominent Naturally Derived Oxidative-Stress-Targeting Drugs and Their Applications in Cancer Treatment
Eunsun Lee, Dongki Yang, Jeong Hee Hong
Antioxidants (2025) Vol. 14, Iss. 1, pp. 49-49
Open Access
Systematic review: Renin-angiotensin system inhibitors in chemoprevention of hepatocellular carcinoma
M. Barone, Maria Teresa Viggiani, Giuseppe Losurdo, et al.
World Journal of Gastroenterology (2019) Vol. 25, Iss. 20, pp. 2524-2538
Open Access | Times Cited: 28
Telmisartan induces melanoma cell apoptosis and synergizes with vemurafenib in vitro by altering cell bioenergetics
Jelena Grahovac, Tatjana Srdić‐Rajić, F. Juan, et al.
Cancer Biology and Medicine (2019) Vol. 16, Iss. 2, pp. 247-247
Open Access | Times Cited: 27
The Angiotensin II Receptor Blocker Losartan Sensitizes Human Liver Cancer Cells to Lenvatinib-Mediated Cytostatic and Angiostatic Effects
Hirotetsu Takagi, Kosuke Kaji, Norihisa Nishimura, et al.
Cells (2021) Vol. 10, Iss. 3, pp. 575-575
Open Access | Times Cited: 22
Astragaloside IV suppresses migration and invasion of TGF-β1-induced human hepatoma HuH-7 cells by regulating Nrf2/HO-1 and TGF-β1/Smad3 pathways
Lili Li, Qin Wang, Yinghao He, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 395, Iss. 4, pp. 397-405
Closed Access | Times Cited: 15
MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen
Richard E. Kast, Alex Alfieri, Hazem Assi, et al.
Cancers (2022) Vol. 14, Iss. 10, pp. 2563-2563
Open Access | Times Cited: 14
Expanding telmisartan’s therapeutic horizon: exploring its multifaceted mechanisms beyond cardiovascular disorders
Yogesh S. Ahire, Vinod Bairagi, Deepak B. Somavanshi, et al.
Future Journal of Pharmaceutical Sciences (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Evidence of Omics, Immune Infiltration, and Pharmacogenomic for SENP1 in the Pan-Cancer Cohort
Somayye Taghvaei, Farzaneh Sabouni, Zarrin Minuchehr
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 15
Inhibition of autophagy enhances adenosine‑induced apoptosis in human hepatoblastoma HepG2 cells
Xiao‐Tao Zhou, Ze‐Jin Pu, Lixuan Liu, et al.
Oncology Reports (2018)
Open Access | Times Cited: 18
Telmisartan attenuates human glioblastoma cells proliferation and oncogenicity by inducing the lipid oxidation
Yan Wang, Tengrui Zhang, Chen Li, et al.
Asia-Pacific Journal of Clinical Oncology (2021) Vol. 18, Iss. 3, pp. 217-223
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top